Medicines must stayed aligned with EU after Brexit, UK health lawmakers warn
MLex Summary: The UK government must be aware of how "seriously adversely affected" the pharmaceuticals sector would be by a "no deal" Brexit outcome, according to Parliament's Health and Social Care...To view the full article, register now.
Already a subscriber? Click here to view full article